Further investigation is needed to elucidate if mitochondrial alteration and dysfunction phenotypes in non-SOD mutants occur at early disease stages as a key gateway in ALS pathogenesis. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.